Inventor · disambiguated record
Leila Sevigny
Also filed as: SEVIGNY LEILA
5 granted patents·6 pending applications·9 citations·filing 2018–2025
68Inventor score
Top patents by PatentIndex Score
11 records- 0186US12195555B2Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-engineeringSANOFI SA·Filed 2023·Granted Jan 14, 2025·1 cites·33 claims
- 0284US10626169B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2018·Granted Apr 21, 2020·8 cites·17 claims
- 0377US12378308B2Anti-NGF antibodies and uses thereofINVETX INC·Filed 2024·Granted Aug 5, 2025·0 cites·27 claims
- 0475US12110322B2Anti-NGF antibodies and uses thereofINVETX INC·Filed 2023·Granted Oct 8, 2024·0 cites·30 claims
- 0574US2025197528A1NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERINGSANOFI SA·Filed 2024·Application pending·0 cites
- 0669US2025011410A1Anti-ngf antibodies and uses thereofINVETX INC·Filed 2022·Application pending·0 cites
- 0766US2025188176A1Anti-il-4ra antibodies and uses thereofINVETX INC·Filed 2024·Application pending·0 cites
- 0865US2025051435A1Anti-il-5 antibodies and uses thereofINVETX INC·Filed 2024·Application pending·0 cites
- 0959US2024117062A1Anti-bcma antibodiesSANOFI SA·Filed 2023·Application pending·0 cites
- 1047US2025257142A1Anti-il-31ra antibodies and uses thereofINVETX INC·Filed 2025·Application pending·0 cites
- 1145US11254737B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2020·Granted Feb 22, 2022·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when Leila Sevigny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →